The potent antioxidant activity and significant inhibition of AChE and BChE by the DMF fraction and the inhibition of cell growth by the EAF and DMF fractions of C. religosa focus on its prospect of affording an efficient treatment for AD and cancer, respectively. This evidence concerns the gene BCHE and Alzheimer disease.